Moderate Evidence

Promising research with growing clinical support from multiple studies

Natural Remedies for COPD (Chronic Obstructive Pulmonary Disease)

Chronic obstructive pulmonary disease (COPD) is a progressive lung condition—most often linked to smoking and environmental exposures—characterized by persistent airflow limitation and breathlessness. Western medicine defines COPD physiologically (reduced FEV1/FVC on spirometry) and focuses on preventing exacerbations, easing symptoms, maintaining function, and improving quality of life. Traditional Chinese Medicine (TCM) frames COPD through patterns such as “Lung and Spleen qi deficiency,” “phlegm-dampness,” or “Lung-kidney qi deficiency,” with goals to strengthen vital energy (qi), transform phlegm, and support resilience. Both systems include “natural” strategies—non-drug therapies, nutrition, and mind–body practices—though they arise from different philosophies and use different tools. From a Western evidence-based standpoint, the strongest nonpharmaceutical therapy is pulmonary rehabilitation (PR): supervised exercise, education, and behavior change that reduce dyspnea and hospitalizations while improving exercise capacity and quality of life. Breathing retraining (for example, pursed-lip breathing and diaphragmatic techniques) can acutely ease shortness of breath, while inspiratory muscle training (IMT) improves inspiratory strength and may enhance exercise tolerance. Nutritional optimization is also important—maintaining healthy weight and protein–energy balance supports respiratory muscles and overall function. Several nutraceuticals have been studied as adjuncts. N‑acetylcysteine (NAC) and carbocisteine, mucolytic antioxidants, have shown small-to-moderate reductions in exacerbations in meta-analyses, especially in people with chronic bronchitis features. Vitamin D supplementation appears to reduce exacerbations primarily in individuals with low baseline vitamin D status. Evidence for omega‑3 fatty acids is preliminary but suggests potential improvements in systemic inflammation and exercise tolerance; combinations of antioxidant vitamins have not shown a,

respiratory Updated March 22, 2026

This content is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare provider before starting, stopping, or changing any supplement or medication regimen.

Western Medicine

Diagnosis

COPD is identified by history (smoking or other exposures, chronic cough, dyspnea), physical exam, and confirmatory spirometry showing a post-bronchodilator FEV1/FVC ratio <0.70. Severity is staged by airflow limitation, symptom burden (CAT or mMRC), exacerbation risk, and imaging where appropriate. Functional capacity may be assessed with the 6‑minute walk test and oxygen saturation monitoring; comorbidities are evaluated to guide care.

Treatments

  • Pulmonary rehabilitation (supervised exercise, education, self-management)
  • Breathing retraining (pursed-lip, diaphragmatic techniques)
  • Inspiratory muscle training (IMT)
  • Smoking cessation support and counseling
  • Vaccinations (influenza, pneumococcal)
  • Nutritional therapy for weight and protein–energy balance
  • Long-acting inhaled bronchodilators (LABA/LAMA) and inhaled corticosteroids for select phenotypes
  • Short-acting bronchodilators for relief
  • Long-term oxygen therapy for severe chronic hypoxemia
  • Noninvasive ventilation in select advanced cases
  • Lung volume reduction procedures or transplantation in highly selected patients
  • Comorbidity management (cardiovascular disease, anxiety, osteoporosis)

Medications

  • albuterol (salbutamol)
  • ipratropium
  • tiotropium
  • umeclidinium
  • glycopyrrolate
  • formoterol
  • salmeterol
  • indacaterol
  • vilanterol
  • budesonide
  • fluticasone
  • beclometasone
  • mometasone
  • roflumilast
  • azithromycin (preventive use in select patients)
  • theophylline (limited use)
  • systemic corticosteroids for acute exacerbations

Limitations

COPD is progressive and heterogeneous; nonpharmacologic and pharmacologic therapies improve symptoms and reduce exacerbations but do not reverse established structural lung damage. Access to high-quality pulmonary rehabilitation can be limited. Medication side effects (e.g., thrush with inhaled steroids, tachycardia with beta-agonists) and variable individual responses are recognized. Nutraceutical data are mixed, with benefits often confined to subgroups (e.g., vitamin D deficiency) and long-term outcomes uncertain.

Evidence: Strong Evidence

Sources

  • GOLD (Global Initiative for Chronic Obstructive Lung Disease) 2024 strategy report summarizes diagnosis, staging, and comprehensive management.
  • A Cochrane review of pulmonary rehabilitation (updated 2015 and subsequent) found clinically meaningful improvements in dyspnea, quality of life, and exercise capacity.
  • ATS/ERS statements support breathing retraining and inspiratory muscle training as adjuncts for select patients.
  • Meta-analyses report NAC and carbocisteine reduce exacerbation rates, particularly in chronic bronchitis phenotypes (e.g., PEACE trial for carbocisteine; pooled NAC analyses).
  • Vitamin D: An individual patient data meta-analysis and subsequent reviews suggest reduced exacerbations among individuals with low baseline 25(OH)D.

Eastern & Traditional Medicine

Traditional Chinese Medicine (Herbal formulas with pattern differentiation)

TCM views COPD as involving deficiency of Lung (and often Spleen/Kidney) qi with accumulation of phlegm-dampness. Treatment aims to tonify qi, support defensive energy, transform phlegm, and ease cough/dyspnea. Herbal prescriptions are individualized to the patient’s pattern and disease phase (stable vs. post-exacerbation).

Techniques

  • Classical formulas such as Bu Fei Tang (to tonify Lung qi) and variations to address phlegm and weakness
  • Adjunct formulas like Yu Ping Feng San (Jade Windscreen) to support resistance in those with frequent infections
  • Commonly used herbs: Astragalus (Huang Qi), Cordyceps (Dong Chong Xia Cao), Schisandra (Wu Wei Zi), Ginseng (Ren Shen), Licorice (Gan Cao), Pinellia (Ban Xia) for phlegm; ephedra (Ma Huang) is traditional but generally avoided due to safety concerns
  • Preparation forms: decoctions, granules, or pills from licensed dispensaries; dietary therapy tailored to pattern (e.g., warm, easily digestible foods for qi deficiency)
Licensed acupuncturists/TCM herbalists (L.Ac., Dipl. OM) Traditional Chinese Medicine physicians Integrative medicine physicians trained in Chinese herbal medicine
Evidence: Emerging Research

Acupuncture (including electroacupuncture)

Within TCM, acupuncture is applied to regulate Lung qi, disperse phlegm, and ease breathlessness; it may also modulate autonomic tone and perceived dyspnea. It is typically provided as a multi-week course alongside standard COPD care.

Techniques

  • Common points include Dingchuan (EX‑B1), Feishu (BL13), Lieque (LU7), Taiyuan (LU9), Zusanli (ST36), and Ren17 (CV17); protocols vary by pattern and practitioner
  • Adjunct techniques: electroacupuncture, auricular acupuncture
  • Breath-focused relaxation during sessions
Licensed acupuncturists (L.Ac.) Medical doctors trained in medical acupuncture
Evidence: Moderate Evidence

Qigong and Tai Chi (mind–body practices within the Chinese tradition)

These gentle movement and breath practices aim to cultivate qi, improve ventilatory mechanics, reduce anxiety, and enhance functional capacity. They can be adapted to limited mobility and practiced alongside pulmonary rehabilitation.

Techniques

  • Baduanjin (Eight Brocades), Liuzijue (Six Healing Sounds), and simplified Tai Chi routines emphasizing coordinated breathing
  • Group or home practice with gradual progression in duration and complexity
Qigong/Tai Chi instructors with experience in chronic disease Integrative rehab programs incorporating mind–body exercise
Evidence: Moderate Evidence

Sources

  • Systematic reviews of TCM formulas for stable COPD (several through 2019–2022) suggest improvements in symptoms, 6‑minute walk distance, and reduced exacerbations when added to standard care; overall risk of bias and heterogeneity are high.
  • Small randomized trials of Astragalus- or Cordyceps-containing prescriptions report improved quality-of-life scores and exercise capacity; confirmatory large RCTs are lacking.
  • Classical TCM texts describe COPD-like patterns and herbal strategies for tonifying Lung qi and transforming phlegm.
  • A 2022 systematic review and meta-analysis of acupuncture for COPD reported improvements in dyspnea and 6‑minute walk distance compared with sham or usual care, with generally low-to-moderate quality evidence.
  • Earlier controlled trials found reductions in perceived breathlessness and improved quality-of-life scores when acupuncture augmented conventional therapy.
  • Systematic reviews (2019–2021) of Tai Chi and Qigong in COPD show improvements in 6‑minute walk distance, dyspnea scores, and health-related quality of life compared with usual care; heterogeneity and risk of bias vary.
  • Individual RCTs suggest additive benefits when mind–body exercise is combined with standard rehabilitation.

Integrative Perspective

A practical integrative plan can place proven Western nonpharmacologic therapies at the foundation—pulmonary rehabilitation, breathing retraining, and individualized exercise—while considering selected Eastern modalities as adjuncts to improve symptoms, coping, and functional capacity. Studies suggest Tai Chi or Qigong can complement rehabilitation with additional gains in walk distance and quality of life, and acupuncture may reduce dyspnea perception when layered onto standard inhaler therapy. Supplements with the most supportive Western evidence as add-ons include mucolytic antioxidants (e.g., N‑acetylcysteine or carbocisteine) and vitamin D for those with low baseline levels. Dietary patterns rich in omega‑3 fats and polyphenol-containing foods may support systemic inflammation control, although clinical effects remain modest. Safety and interactions: Herb–drug interactions are a key consideration. Ephedra (Ma Huang) should be avoided in COPD given risks of tachycardia and hypertension and potential additive effects with beta‑agonist inhalers. Licorice (Glycyrrhiza) can raise blood pressure and lower potassium, with added risk when combined with diuretics or systemic corticosteroids. Astragalus has immune‑modulating effects and may be inappropriate for some autoimmune conditions or post‑transplant states. Cordyceps and Ginkgo may increase bleeding risk when combined with anticoagulants/antiplatelets. St. John’s Wort (not a TCM herb) can lower theophylline and roflumilast levels via enzyme induction. Quality control is critical for botanicals: choose products with third‑party testing (e.g., USP, NSF) to reduce contamination and adulteration risks; Cordyceps products are frequently adulterated, and some imported formulas have been found with heavy metals or unlabeled pharmaceuticals. Monitoring: Clinicians may consider tracking symptom scores (CAT or mMRC), exacerbation frequency, 6‑minute walk distance, and oxygen saturation over time to evaluate adjunctive therapies. When adding botanicals with potential hepatic or hemostatic effects, periodic liver function tests and coagulation monitoring (for patients on anticoagulants) can be prudent. Introduce one change at a time, reassessing benefit and tolerance. When to seek urgent care: rapidly worsening shortness of breath unrelieved by rescue medication, new confusion, severe chest pain, lips or fingertips turning blue or gray, or signs of infection with high fever warrant immediate medical evaluation. Communication tips: bring a complete list of supplements and herbal products to appointments; discuss goals (fewer exacerbations, more stamina, less anxiety); agree on how benefits and risks will be tracked. Key research gaps include large, rigorously controlled trials of standardized TCM formulas, better phenotyping to match patients with therapies (e.g., chronic bronchitis vs. emphysema-predominant), and long-term outcomes for mind–body interventions. Consult your healthcare provider before making changes to your health regimen.

Sources

  1. GOLD 2024 Global Strategy for the Diagnosis, Management, and Prevention of COPD.
  2. Cochrane Review: Pulmonary rehabilitation for COPD (comprehensive improvements in dyspnea, HRQoL, exercise capacity).
  3. ATS/ERS statements on respiratory muscle training and nonpharmacological management in COPD.
  4. Meta-analyses on NAC and carbocisteine showing reduced exacerbations, particularly in chronic bronchitis phenotypes.
  5. Vitamin D in COPD: individual patient data meta-analyses indicating reduced exacerbations in vitamin D-deficient individuals.
  6. Systematic reviews of acupuncture for COPD (up to 2022) demonstrating improvements in dyspnea and 6MWD with low-to-moderate certainty.
  7. Systematic reviews of Tai Chi/Qigong in COPD (2019–2021) showing gains in exercise capacity and quality of life.
  8. Systematic reviews of TCM herbal formulas as add-ons in stable COPD showing symptom and functional benefits with notable heterogeneity and risk of bias.

Related Content

comparisons

Alternatives for Chronic Obstructive Pulmonary Disease (COPD): East vs West

Alternatives for Chronic Obstructive Pulmonary Disease (COPD). Chronic obstructive pulmonary disease (COPD) is a progressive condition characterized by airflow limitation, chronic breathlessness, cough, and frequent exacerbations. Western biomedical care focuses on three goals: control daily symptoms, prevent exacerbations and hospitalizations, and slow functio

relationships

COPD and Heart Disease

COPD and heart disease frequently coexist and influence one another through shared risk factors, overlapping pathophysiology, and intersecting treatments. Cigarette smoking, aging, air pollution, phys

comparisons

Acupuncture for Chronic Bronchitis: East vs West

Acupuncture for Chronic Bronchitis. Chronic bronchitis is a clinical syndrome defined by a chronic productive cough for at least three months per year over two consecutive years, commonly occurring within the broader spectrum of chronic obstructive pulmonary disease (COPD). From a western medical perspective, airway inflammation, mucu

comparisons

Natural Remedies for Obesity — West vs East: East vs West

Natural Remedies for Obesity — West vs East. Obesity is a chronic, relapsing condition shaped by biology, behavior, and environment. Western medicine typically defines it by body mass index (BMI ≥30 kg/m² for adults), waist circumference, and body composition, alongside metabolic markers such as fasting glucose, HbA1c, lipid profile, blood pre

comparisons

Coronary Artery Disease — Herbal Remedies (West vs East): East vs West

Coronary Artery Disease — Herbal Remedies (West vs East). Coronary artery disease (CAD) arises when atherosclerotic plaque narrows or blocks the coronary arteries, reducing blood flow to the heart muscle. The biomedical goals of care are clear: prevent heart attacks and strokes, reduce symptoms like angina, and extend healthy life through risk-factor contr

comparisons

Alternative Medicine for Smoking Cessation: East vs West

Alternative Medicine for Smoking Cessation. Quitting smoking is one of the most powerful steps a person can take to protect long‑term health, yet nicotine dependence has both biological and behavioral roots that make stopping difficult. Comparing Western and Eastern approaches helps clarify how different systems frame addiction, what compleme

Health Disclaimer

This content is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare provider before starting, stopping, or changing any supplement or medication regimen.